Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Ascendis Pharma A/S

Ascendis Pharma A/S (ASND)

Market is closed
News
Ascendis Pharma A/S (NASDAQ:ASND) Q4 2023 Earnings Call Transcript

Ascendis Pharma A/S (NASDAQ:ASND) Q4 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Fourth Quarter 2023 Ascendis Pharma Earnings Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

February 8th, 2024 - News Transcripts

Ascendis Pharma A/S (NASDAQ:ASND) Q3 2023 Earnings Call Transcript

Ascendis Pharma A/S (NASDAQ:ASND) Q3 2023 Earnings Call Transcript

Operator: Hello, and welcome to Ascendis Pharma Third Quarter 2023 Earnings Conference Call and Webcast.

Keep Reading →

November 8th, 2023 - News Transcripts

Here’s What Caused the Volatility in Ascendis Pharma A/S (ASND)

Here’s What Caused the Volatility in Ascendis Pharma A/S (ASND)

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter investor letter. A copy of the same can be downloaded here.

Keep Reading →

September 22nd, 2023 - Hedge Fund Investor Letters News

Ascendis Pharma A/S (NASDAQ:ASND) Q2 2023 Earnings Call Transcript

Ascendis Pharma A/S (NASDAQ:ASND) Q2 2023 Earnings Call Transcript

Operator: Hello, and welcome to Ascendis Pharma Q2 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

September 6th, 2023 - News Transcripts

Here’s Why Ascendis Pharma A/S (ASND) Declined in Q2

Here’s Why Ascendis Pharma A/S (ASND) Declined in Q2

Artisan Partners, an investment management company, released its “Artisan Global Discovery Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here.

Keep Reading →

August 24th, 2023 - Hedge Fund Investor Letters News

15 Worst Performing Biotech Stocks in 2023

15 Worst Performing Biotech Stocks in 2023

In this article, we discuss 15 worst performing biotech stocks in 2023.

Keep Reading →

August 8th, 2023 - Hedge Funds News Stock Analysis

Here’s Why Baron Health Care Fund Harvested Ascendis Pharma A/S (ASND)

Here’s Why Baron Health Care Fund Harvested Ascendis Pharma A/S (ASND)

Baron Funds, an investment management company, released its “Baron Health Care Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here.

Keep Reading →

July 25th, 2023 - Hedge Fund Investor Letters News

Ascendis Pharma A/S (NASDAQ:ASND) Q1 2023 Earnings Call Transcript

Operator: Thank you for standing by and welcome to the Q1 2023 Ascendis Pharma Earnings Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

May 4th, 2023 - News Transcripts

Top 5 Growth Stocks in Biotech

Top 5 Growth Stocks in Biotech

Headquartered in Bermuda, Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) is a biopharmaceutical company focusing on therapeutics for debilitating disorders.

Keep Reading →

March 28th, 2023 - News

Ascendis Pharma A/S (NASDAQ:ASND) Q4 2022 Earnings Call Transcript

Ascendis Pharma A/S (NASDAQ:ASND) Q4 2022 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Ascendis Pharma Full Year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

February 20th, 2023 - News Transcripts

Insider Monkey Quarterly Strategy
+334.6% Insider Monkey Quarterly Strategy
+149.4% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)